Login to Your Account



Other News To Note


Wednesday, November 27, 2013
• Evoke Pharma Inc., of San Diego, selected Synteracthcr Inc. to serve as its primary contract research organization for its upcoming Phase III trial with EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription